登录 | 注册    关注公众号  
微信公众号
搜索
 > 【PD-L2】

PD-L2信息

英文名称:Programmed death-ligand 2
中文名称:程序性死亡配体2
靶点别称:PDCD1LG2,PDL2,Programmed death ligand 2,CD273,Butyrophilin B7-DC,PD-1 ligand 2,B7-DC,BA574F11.2,PDCD1L2,CD273 Antigen,B7DC,Btdc,B7 Dendritic Cell Molecule,PD-1-Ligand 2,PDCD1 ligand 2,Programmed cell death 1 ligand 2
上市药物数量:0
临床药物数量:1
最高研发阶段:临床一期

PD-L2分子别名

PDL2,PD-L2,Butyrophilin B7-DC,CD273,PDCD1 ligand 2,PDCD1L2,PDCD1LG2

PD-L2分子背景

Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

PD-L2临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定